Brief: Proteomics International Laboratories Says US Patent Secured For Promarkereso Diagnostic Test
17/12/2025 01:17
Dec 17 (Reuters) - Proteomics International Laboratories Ltd PIQ.AX: US PATENT SECURED FOR PROMARKERESO DIAGNOSTIC TEST FOR ESOPHAGEAL ADENOCARCINOMA Further company coverage: PIQ.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Proteomics International Laboratories
See all newsBrief: Proteomics International Laboratories Launches Share Purchase Plan To Raise Up To A$5 MLN
Australia's Proteomics slips to four-month low on discounted share sale plan
Brief: Proteomics International Laboratories Posts FY Loss Attributable A$8.6 Million
Brief: Proteomics International Laboratories Signs Agreement With Healius For Promarker Portfolio
Australia's Proteomics International soars on distribution deal with Healius